Skewed Production of IL-6 and TGFβ by Cultured Salivary Gland Epithelial Cells from Patients with Sjögren's Syndrome

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Kawanami, Takafumi ^a   Sawaki, Toshioki ^a   Sakai, Tomoyuki ^a   Miki, Miyuki ^a   Iwao, Haruka ^a   Nakajima, Akio ^a   Nakamura, Takuji ^a   Sato, Tomomi ^a   Fujita, Yoshimasa ^a   Tanaka, Masao ^a   Masaki, Yasufumi ^a   Fukushima, Toshihiro ^a   Hirose, Yuko ^a   Taniguchi, Makoto ^a   Sugimoto, Naotoshi ^b   Okazaki, Toshiro ^a   Umehara, Hisanori ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PROTEIN EXPRESSION; SALIVARY GLAND; SJOEGREN SYNDROME;

ADULT; AGED; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; EPITHELIAL CELLS; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-6; MALE; MIDDLE AGED; SALIVARY GLANDS; SJOGREN'S SYNDROME; TRANSFORMING GROWTH FACTOR BETA;

EID: 84868130705     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045689     Document Type: Article

References (31)

1. Fox RI, (2005) Sjögren's syndrome. Lancet 366: 321-331.
2. Umehara H, Dong L, Masaki Y, Tanaka M, Fukushima T, et al. (2007) Sjögren's syndrome and lymphoma development. Curr Immunol Rev 3: 289-296.
3. McInnes IB, Liew FY, (2005) Cytokine networks-towards new therapies for rheumatoid arthritis. Nat Clin Pract Rheumatol 1: 31-39.
4. Ramos-Casals M, Tzioufas AG, Stone JH, Siso A, Bosch X, (2010) Treatment of primary Sjögren's syndrome: a systematic review. JAMA 304: 452-460.
5. Youinou P, Pers JO, (2011) Disturbance of cytokine networks in Sjögren's syndrome. Arthritis Res Ther 13: 227.
6. Oxholm P, Daniels TE, Bendtzen K, (1992) Cytokine expression in labial salivary glands from patients with primary Sjögren's syndrome. Autoimmunity 12: 185-191.
7. Fox RI, Kang HI, Ando D, Abrams J, Pisa E, (1994) Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol 152: 5532-5539.
8. Ohyama Y, Nakamura S, Matsuzaki G, Shinohara M, Hiroki A, et al. (1996) Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 39: 1376-1384.
9. Reksten TR, Jonsson MV, Szyszko EA, Brun JG, Jonsson R, et al. (2009) Cytokine and autoantbody profiling related to histopathological features in primary Sjögren's syndrome. Rheumatology 48: 1102-1106.
10. Hjelmervik TO, Petersen K, Jonassen I, Jonsson R, Bolstad AI, (2005) Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects. Arthritis Rheum 52: 1534-1544.
11. Ogawa N, Ping L, Zhenjun L, Takada Y, Sugai S, (2002) Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome. Arthritis Rheum 46: 2730-2741.
12. Ogawa N, Kawanami T, Shimoyama K, Ping L, Sugai S, (2004) Expression of interferon-inducible T cell alpha chemoattractant (CXCL11) in the salivary glands of patients with Sjögren's syndrome. Clin Immunol 112: 235-238.
13. Ping L, Ogawa N, Sugai S, (2005) Novel role of CD40 in Fas-dependent apoptosis of cultured salivary epithelial cells from patients with Sjögren's syndrome. Arthritis Rheum 52: 573-581.
14. Dang H, Geiser AG, Letterio JJ, Nakabayashi T, Kong L, et al. (1995) SLE-like autoantibodies and Sjogren's syndrome-like lymphoproliferation in TGF-beta knockout mice. J Immunol 155: 3205-3212.
15. Nakabayashi T, Letterio JJ, Geiser AG, Kong L, Ogawa N, et al. (1997) Up-regulation of cytokine mRNA, adhesion molecule proteins, and MHC class II proteins in salivary glands of TGF-beta1 knockout mice: MHC class II is a factor in the pathogenesis of TGF-beta1 knockout mice. J Immunol 158: 5527-5535.
16. Veldhoen M, Hocking RJ, Flavell RA, Stockinger B, (2006) Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat Immunol 7: 1151-1156.
17. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B, (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
18. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
19. Daniels TE, Criswell LA, Shiboski C, Shiboski S, Lanfranchi H, et al. (2009) Sjögren's International Collaborative Clinical Alliance Research Groups. An early view of the International Sjogren's syndrome registry. Arthritis Rheum 61: 711-714.
20. Malladi AS, Sack KE, Shiboski SC, Shiboski CH, Baer AN, et al. (2012) Primary Sjögren's syndrome as a systemic disease: a study of participants enrolled in an international Sjogren's syndrome registry. Arthritis Care Res 64: 911-918.
21. Shiboski SC, Shiboski CH, Criswell LA, Baer AN, Challacombe S, et al. (2012) Sjogren's International Collaborative Clinical Alliance (SICCA) Research Groups. American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjogren's International Collaborative Clinical Alliance Cohort. Arthritis Care Res 64: 475-787.
22. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, et al. (2002) European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61: 554-558.
23. Miyaji M, Jin ZX, Yamaoka S, Amakawa R, Fukuhara S, et al. (2005) Role of membrane sphingomyelin and ceramide in platform formation for Fas-mediated apoptosis. J Exp Med 202: 249-259.
24. Wakamatsu E, Matsumoto I, Yasukochi T, Naito Y, Goto D, Mamura M, et al. (2006) Overexpression of phosphorylated STAT-1alpha in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 54: 3476-3484.
25. van Woerkom JM, Kruize AA, Wenting-van Wijk MJG, Knol E, Bihari IC, et al. (2005) Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjogren's syndrome compared with non- Sjögren's sicca syndrome. Ann Rheum Dis 64: 1474-1479.
26. Yoshimura A, Wakabayashi Y, Mori T, (2010) Cellular and molecular basis for the regulation of inflammation by TGF-beta. J Biochem 147: 781-792.
27. Romagnani S, (2008) Human Th17 cells. Arthritis Res Ther 10: 206.
28. Naka T, Nishimoto N, Kishimoto T, (2002) The paradigm of IL-6: from basic science to medicine. Arthritis Res 4 (Suppl 3):: S233-S242.
29. Nishimoto N, Kanakura Y, Aozasa K, Johkoh T, Nakamura M, et al. (2005) Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood 106: 2627-2632.
30. Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM, (2009) Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis. Am J Pathol 175: 1167-1177.
31. Szyszko EA, Brokstad KA, Oijordsbakken G, Jonsson MV, Jonsson R, et al. (2011) Salivary glands of primary Sjögren's syndrome patients express factors vital for plasma cell survival. Arthritis Res Ther 13: R2.